Press Releases

Want to know the latest about PrimeraDx? Visit our press room often to learn the latest developments about our growing company, including speaking engagements and conference and trade show exhibitions.

Mar 26th: PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
Oct 3rd: FierceMedicalDevices Names PrimeraDx as one of its “Fierce 15” Medical Device and Diagnostic Companies of 2012
Sep 25th: National Cancer Institute Awards PrimeraDx Grant to Develop B-Cell Lymphoma Panel on ICEPlex System
Sep 12th: PrimeraDx Receives CE Marks for the ICEPlex System and C. difficile Detection Assay
Jun 26th: PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Jan 18th: PrimeraDx Receives ISO 13485:2003 Certification
Jan 3rd: PrimeraDx Appoints David Jackson as VP of Business Development
Dec 6th: PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board
Dec 1st: PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development
Sep 22nd: PrimeraDx Appoints Albert A. Luderer to its Board of Directors
Aug 23rd: PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA, and DNA
Aug 2nd: PrimeraDx Names Fayyaz Memon, Vice President of Regulatory Affairs and Quality Assurance
Aug 30th: PrimeraDx Names Matthew F. McManus, M.D., Ph.D., President and Chief Executive Officer
Mar 22nd: PrimeraDx Announces the Expansion of its Senior Management Team
Oct 5th: PrimeraDx Awarded 4th Patent Covering STAR Technology
Sep 7th: PrimeraDx closes $20m Series C
Jan 7th: PrimeraDx announces the Expansion of its Senior Management Team
Dec 1st: PrimeraDx Appoints Ted Myles as Chief Financial Officer
Jul 14th: PrimeraDx Appoints George N. Serbedzija as Vice President of Business Development
May 24th: PrimeraDx Receives Issuance of Key Patent
Feb 24th: PrimeraDx Names Robert J. Rosenthal, Ph.D., Director to the Board
Jan 7th: Primera Raises $21M in Series B funding
Aug 23rd: Primera Biosystems Introduces ViraQuant™ – The First Multiplexed Quantitative Viral Test for the Simultaneous Detection of CMV, EBV, BKV, HHV6 and HHV7
Mar 20th: PrimeraDx Names Martin L. Verhoef President and Chief Executive Officer